These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4146331)

  • 1. On the question of subclassification of -adrenoceptors.
    Janis RA; Triggle DJ
    J Pharm Pharmacol; 1973 Mar; 25(3):263-4. PubMed ID: 4146331
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of adrenergic alpha-receptors by the use of NN-dimethyl-2-bromo-2-phenylethylamine (DMPEA).
    Janis RA; Triggle DJ
    J Pharm Pharmacol; 1971 Sep; 23(9):707-8. PubMed ID: 4398251
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Halogenoethylamines and the role of Ca 2+ in adrenergic -receptor activation in the rat vas deferens.
    Swamy VC; Triggle DJ
    Eur J Pharmacol; 1972 Jul; 19(1):67-78. PubMed ID: 4340228
    [No Abstract]   [Full Text] [Related]  

  • 4. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
    Eltze M; König H; Ullrich B; Grebe T
    Eur J Pharmacol; 2001 Mar; 415(2-3):265-76. PubMed ID: 11275009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat.
    Doxey JC; Gadie B; Lane AC; Tulloch IF
    Br J Pharmacol; 1983 Sep; 80(1):155-61. PubMed ID: 6140052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,4-Benzodioxanes as reversible and irreversible antagonists at adrenergic receptors.
    Avner BP; Triggle DJ
    J Med Chem; 1974 Feb; 17(2):197-200. PubMed ID: 4148932
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha (1D)-adrenoceptor antagonist BMY 7378 is also an alpha (2C)-adrenoceptor antagonist.
    Cleary L; Murad K; Bexis S; Docherty JR
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):135-41. PubMed ID: 16176444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens.
    Drew GM
    Eur J Pharmacol; 1977 Mar; 42(2):123-30. PubMed ID: 14838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. -Adrenoceptors of aortae from genetically hypertensive rats: reaction with 2-halogenoethylamines.
    Janis RA; Triggle DJ
    J Pharm Pharmacol; 1972 Aug; 24(8):602-8. PubMed ID: 4403739
    [No Abstract]   [Full Text] [Related]  

  • 15. Irreversible adrenergic -receptor antagonism by (R)-and (S)-N-(2-chloroethyl)-N-methyl-2-phenyl-2-hydroxyethylamine and related agents.
    McLean S; Swamy VC; Tomei D; Triggle DJ
    J Med Chem; 1973 Jan; 16(1):54-7. PubMed ID: 4404822
    [No Abstract]   [Full Text] [Related]  

  • 16. Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.
    Eltze M; König H; Ullrich B; Grebe T
    Eur J Pharmacol; 1999 Jul; 378(1):69-83. PubMed ID: 10478567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
    Hancock AA; Buckner SA; Brune ME; Esbenshade TA; Ireland LM; Katwala S; Milicic I; Meyer MD; Kerwin JF; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):478-86. PubMed ID: 11805207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-adrenoceptor agonists and antagonists and of antidepressant drugs on pre- and postsynaptic alpha-adrenoceptors.
    Brown J; Doxey JC; Handley S
    Eur J Pharmacol; 1980 Oct; 67(1):33-40. PubMed ID: 6106552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade.
    Pupo AS; Cavenaghi DL; Campos M; Lucena Morais P; Jurkiewicz NH; Jurkiewicz A
    Br J Pharmacol; 1999 Aug; 127(8):1832-6. PubMed ID: 10482913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and alpha-adrenolytic activity of chiral beta-haloethylamines.
    Riley TN; Crawford FW
    J Pharm Sci; 1976 Apr; 65(4):544-7. PubMed ID: 5589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.